Fecal microbiota transplantation and donor screening for Clostridioides difficile infection during COVID-19 pandemic.
作者信息
Chiu Cheng-Hsun, Tsai Ming-Chao, Cheng Hao-Tsai, Le Puo-Hsien, Kuo Chia-Jung, Chiu Cheng-Tang
机构信息
Division of Pediatric Infectious Diseases, Department of Pediatrics, Linkou Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan; Chang Gung Microbiota Therapy Center, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University, Kaohsiung, Taiwan.
出版信息
J Formos Med Assoc. 2021 Feb;120(2):791-793. doi: 10.1016/j.jfma.2020.07.028. Epub 2020 Jul 23.
Abstract
摘要
相似文献
1
Fecal microbiota transplantation and donor screening for Clostridioides difficile infection during COVID-19 pandemic.2019年冠状病毒病大流行期间艰难梭菌感染的粪便微生物群移植及供体筛查
J Formos Med Assoc. 2021 Feb;120(2):791-793. doi: 10.1016/j.jfma.2020.07.028. Epub 2020 Jul 23.
2
Fecal Microbiota Transplantation for Recurrent Clostridioides difficile infection: The COVID-19 Era.粪便微生物群移植治疗复发性艰难梭菌感染：新冠疫情时代
Am J Gastroenterol. 2020 Jul;115(7):971-974. doi: 10.14309/ajg.0000000000000689.
3
[Reconsidering the technical aspects and quality management background of faecal microbiota transplantation due to the novel coronavirus pandemic].[鉴于新型冠状病毒大流行重新审视粪便微生物群移植的技术方面和质量管理背景]
Orv Hetil. 2020 Nov 1;161(44):1858-1871. doi: 10.1556/650.2020.32023.
4
Enhanced donor screening for faecal microbial transplantation during COVID-19.新冠疫情期间粪便微生物移植供体筛查的强化措施
Gut. 2021 Nov;70(11):2219-2220. doi: 10.1136/gutjnl-2021-324593. Epub 2021 Mar 31.
5
The interplay of SARS-CoV-2 and infection.SARS-CoV-2 与 感染的相互作用。
Future Microbiol. 2021 Apr;16:439-443. doi: 10.2217/fmb-2020-0275. Epub 2021 Apr 13.
6
High prevalence of extended-spectrum beta-lactamase organisms and the COVID-19 pandemic impact on donor recruitment for fecal microbiota transplantation in Hong Kong.香港产 ESBL 菌的高流行率和 COVID-19 大流行对粪便微生物移植供体招募的影响。
United European Gastroenterol J. 2021 Nov;9(9):1027-1038. doi: 10.1002/ueg2.12160. Epub 2021 Oct 8.
7
Fecal Microbiota Transplantation for Clostridioides difficile Infection in Immunocompromised Hosts.免疫功能低下宿主艰难梭菌感染的粪便微生物群移植
Clin Infect Dis. 2021 Jun 15;72(12):2247. doi: 10.1093/cid/ciz689.
8
Fecal Microbiota Transplantation Is Effective for the Treatment of Partially Treated Infection.粪便微生物群移植对部分治疗的感染有效。
Gut Liver. 2021 Jan 15;15(1):1-2. doi: 10.5009/gnl20368.
9
Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults: Treat Early, Treat Often.粪菌移植治疗高危老年患者艰难梭菌感染：尽早治疗，多次治疗。
Dig Dis Sci. 2020 Dec;65(12):3425-3427. doi: 10.1007/s10620-020-06291-6.
10
Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence.高风险老年人群中艰难梭菌的粪便微生物移植与早期复发相关。
Dig Dis Sci. 2020 Dec;65(12):3647-3651. doi: 10.1007/s10620-020-06147-z. Epub 2020 Feb 20.
引用本文的文献
1
Comparative Efficacy of Fecal Microbiota Transplantation in Treating Refractory or Recurrent Infection among Patients with and without Inflammatory Bowel Disease: A Retrospective Cohort Study.粪便微生物群移植治疗炎症性肠病患者与非炎症性肠病患者难治性或复发性感染的疗效比较：一项回顾性队列研究
Biomedicines. 2024 Jun 23;12(7):1396. doi: 10.3390/biomedicines12071396.
2
Application and development of fecal microbiota transplantation in the treatment of gastrointestinal and metabolic diseases: A review.粪便微生物群移植在治疗胃肠和代谢疾病中的应用和发展：综述。
Saudi J Gastroenterol. 2023 Jan-Feb;29(1):3-11. doi: 10.4103/sjg.sjg_131_22.
3
Current and future applications of fecal microbiota transplantation for children.粪便微生物群移植在儿童中的应用现状和未来展望。
Biomed J. 2022 Feb;45(1):11-18. doi: 10.1016/j.bj.2021.11.004. Epub 2021 Nov 12.
4
Implementation of fecal microbiota transplantation in a medical center for recurrent or refractory Clostridioides difficile infection and report of preliminary outcome.粪便微生物群移植在一家医疗中心治疗复发性或难治性艰难梭菌感染中的应用及初步结果报告。
Biomed J. 2022 Jun;45(3):504-511. doi: 10.1016/j.bj.2021.06.001. Epub 2021 Jun 9.
5
Washed microbiota transplantation in patients with respiratory spreading diseases: Practice recommendations.呼吸道传播疾病患者的经清洗微生物群移植：实践建议。
Med Microecol. 2021 Mar;7:100024. doi: 10.1016/j.medmic.2020.100024. Epub 2020 Oct 10.
6
Should We Be Worried About During the SARS-CoV2 Pandemic?在新冠疫情期间我们应该担心……吗？ （原文“about”后内容缺失）
Front Microbiol. 2020 Sep 29;11:581343. doi: 10.3389/fmicb.2020.581343. eCollection 2020.
本文引用的文献
1
Comparison of Clinical Characteristics of Patients with Asymptomatic vs Symptomatic Coronavirus Disease 2019 in Wuhan, China.中国武汉无症状与有症状新冠肺炎患者的临床特征比较。
JAMA Netw Open. 2020 May 1;3(5):e2010182. doi: 10.1001/jamanetworkopen.2020.10182.
2
Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020.2020 年 3 月-4 月，美国密歇根州底特律市，COVID-19 患者中的艰难梭菌。
Emerg Infect Dis. 2020 Sep;26(9):2272-4. doi: 10.3201/eid2609.202126. Epub 2020 May 22.
3
Drug-Resistant Bacteremia after Fecal Microbiota Transplant.粪便微生物群移植后的耐药菌血症
N Engl J Med. 2020 May 14;382(20):1960-1961. doi: 10.1056/NEJMc2002496.
4
Screening FMT donors during the COVID-19 pandemic: a protocol for stool SARS-CoV-2 viral quantification.在2019冠状病毒病大流行期间筛查粪菌移植供体：粪便严重急性呼吸综合征冠状病毒2病毒定量方案
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):642-643. doi: 10.1016/S2468-1253(20)30124-2. Epub 2020 Apr 22.
5
COVID-19 and immunomodulation in IBD.COVID-19 与 IBD 中的免疫调节。
Gut. 2020 Jul;69(7):1335-1342. doi: 10.1136/gutjnl-2020-321269. Epub 2020 Apr 17.
6
Trends in U.S. Burden of Infection and Outcomes.美国感染负担和结局的趋势。
N Engl J Med. 2020 Apr 2;382(14):1320-1330. doi: 10.1056/NEJMoa1910215.
7
Screening faecal microbiota transplant donors for SARS-CoV-2 by molecular testing of stool is the safest way forward.通过对粪便进行分子检测来筛查严重急性呼吸综合征冠状病毒2（SARS-CoV-2）粪便微生物群移植供体是最安全的前进方式。
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):531. doi: 10.1016/S2468-1253(20)30089-3. Epub 2020 Mar 30.
8
What Should Gastroenterologists and Patients Know About COVID-19?胃肠病学家和患者应该了解哪些关于新冠病毒的知识？
Clin Gastroenterol Hepatol. 2020 Jun;18(7):1409-1411. doi: 10.1016/j.cgh.2020.03.020. Epub 2020 Mar 18.
9
Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel.2019冠状病毒病疫情期间粪便微生物群移植供体的筛查：国际专家小组提出的紧急更新建议
Lancet Gastroenterol Hepatol. 2020 May;5(5):430-432. doi: 10.1016/S2468-1253(20)30082-0. Epub 2020 Mar 17.
10
SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics.儿童感染新型冠状病毒2：传播动态与临床特征
J Formos Med Assoc. 2020 Mar;119(3):670-673. doi: 10.1016/j.jfma.2020.02.009. Epub 2020 Mar 2.
Zotero 插件